Identité

Testosterone Impurity 25

Non indiqué · C21H30O5

01Identité

Lazychem IDLC-51733
CAS RNNon indiqué
PubChem CID172080
Molecular formulaC21H30O5
Molecular weight362.5 g/mol
IUPAC name2-[[(10S,13S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-10-yl]methoxy]acetic acid
InChIKeyRVZZNRRLHHTDMN-BUXGSPBHSA-N

02Structure et stéréochimie

2D structurePubChem CID 172080
Two-dimensional chemical structure of Testosterone Impurity 25
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 4 rings, includes aliphatic carbon, has 3 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres3
Ring count4
Secondary amines0
Tertiary amines0
SMILESC[C@]12CCC3C(C1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34COCC(=O)O
InChINon indiqué

03Stereochemistry

The published structure contains 3 defined and 3 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres3Structure assigned
Unassigned centres3Structure unspecified
Assignment statusPartially assignedExact published identity
Tetrahedral upper bound≤ 64Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Statut en Inde

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Noms et relations

API et médicament parent

Non indiqué

Noms et relations

    Impuretés et composés apparentés

      06Sources